<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />
    <title>James Routley | Feed</title>
    <link
      rel="stylesheet"
      type="text/css"
      href="../styles.css"
      media="screen"
    />
  </head>
  <body>
    <a href="/index.html">Back</a>
    <a href="https://www.ldeming.com/longevityfaq">Original</a>
    <h1>Longevity FAQ: A beginner&#39;s guide to longevity research</h1>
    
    <div id="readability-page-1" class="page"><div>
				
				<tr>
					<td data-title="Intervention">Senescent cell removal</td>
					<td data-title="Median lifespan increase (treated/control)">135%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Does not affect rotarod performance, object discrimination. Slight delay in wound closure.</td>
					<td data-title="Reference">1</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Rapamycin</td>
					<td data-title="Median lifespan increase (treated/control)">110%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">Late-life rapamyicn treatment extends lifespan (pooled females from multiple-site NIA study)</td>
					<td data-title="Reference">2</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">NR</td>
					<td data-title="Median lifespan increase (treated/control)">105%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Claim an increase in running distance</td>
					<td data-title="Reference">3</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Catalase</td>
					<td data-title="Median lifespan increase (treated/control)">117%</td>
					<td data-title="Year Published">2005</td>
					<td data-title="Notes">Mitochondrially-targeted catalase expression extended mouse lifespan compared to control</td>
					<td data-title="Reference">4</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Sirt6 overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">115%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Sirt6-overexpression increases male mouse lifespan</td>
					<td data-title="Reference">5</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Metformin</td>
					<td data-title="Median lifespan increase (treated/control)">106%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">In males, small but significant lifespan extension after metformin application</td>
					<td data-title="Reference">6</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">DN-IκBα</td>
					<td data-title="Median lifespan increase (treated/control)">110%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Dominant negative to downregulate IKK-beta activity, delivered to hypothalamus of middle-aged mice</td>
					<td data-title="Reference">7</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Klotho</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2005</td>
					<td data-title="Notes">Overexpression under human elongation factor 1α promoter increases lifespan, slight fertility loss</td>
					<td data-title="Reference">8</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">S6K1</td>
					<td data-title="Median lifespan increase (treated/control)">118%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">KO of S6K1 extends lifspan compared to wildtype mice</td>
					<td data-title="Reference">9</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">p66</td>
					<td data-title="Median lifespan increase (treated/control)">128%</td>
					<td data-title="Year Published">1999</td>
					<td data-title="Notes">Mutation of a p66shc, member of proto-oncogene locus SHC, extends lifespan. May be just due to cancer effect.</td>
					<td data-title="Reference">10</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Lowering protein:carbohydrate ratio</td>
					<td data-title="Median lifespan increase (treated/control)">128%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Varied protein, carbohydrate, and total energy levels.</td>
					<td data-title="Reference">11</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Fat-specific insulin receptor knockout mice</td>
					<td data-title="Median lifespan increase (treated/control)">111%</td>
					<td data-title="Year Published">2003</td>
					<td data-title="Notes">Fat-specific insulin receptor knockout mice show a significant increase in lifespan</td>
					<td data-title="Reference">12</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">C57BL/6 mice with NZB/OlaHsd mitochondrial mutations</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Same nuclear, different mitochondrial DNA.</td>
					<td data-title="Reference">13</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Fasting mimicking diet</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">FMD followed by 10 days of normal, then repeat</td>
					<td data-title="Reference">14</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Rapamycin</td>
					<td data-title="Median lifespan increase (treated/control)">127%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Rapamycin from 9 months of age, weight decreased ~30% at highest dose</td>
					<td data-title="Reference">15</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Brain-specific Sirt1 expression</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Brain-specific Sirt1 expression in female mice increases lifespan over wildtype</td>
					<td data-title="Reference">16</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">SRT1720</td>
					<td data-title="Median lifespan increase (treated/control)">104%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Start diet at 28 weeks of age, very small increase on lifespan</td>
					<td data-title="Reference">17</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Spermidine</td>
					<td data-title="Median lifespan increase (treated/control)">111%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Polyamine, administered in drinking water</td>
					<td data-title="Reference">18</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Atg5 overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">117%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Transgenic mice ubiquitously expressing Atg5 (crucial for autophagasome confirmation) live longer.</td>
					<td data-title="Reference">19</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Telomerase</td>
					<td data-title="Median lifespan increase (treated/control)">124%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Paper showing telomerase therapy increasing life</td>
					<td data-title="Reference">20</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Insulin receptor substrate null</td>
					<td data-title="Median lifespan increase (treated/control)">132%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">Insulin receptor substrate 1 null mouse lifespan extension in females</td>
					<td data-title="Reference">21</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Snell Dwarf Mice</td>
					<td data-title="Median lifespan increase (treated/control)">142%</td>
					<td data-title="Year Published">2001</td>
					<td data-title="Notes">Snell dwarf mouse paper showing life extension</td>
					<td data-title="Reference">22</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Ames Dwarf Mice</td>
					<td data-title="Median lifespan increase (treated/control)">168%</td>
					<td data-title="Year Published">1996</td>
					<td data-title="Notes">Original Ames dwarf mouse paper showing life extension</td>
					<td data-title="Reference">23</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">s-Arf/p53</td>
					<td data-title="Median lifespan increase (treated/control)">113%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">An extra copy of p53 and upstream regulator Arf/p16Ink4a increases lifespan</td>
					<td data-title="Reference">24</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Slow growth during lactation</td>
					<td data-title="Median lifespan increase (treated/control)">106%</td>
					<td data-title="Year Published">2004</td>
					<td data-title="Notes">Male mice suckled by dams fed a low-protein diet lived longer than their control cohort</td>
					<td data-title="Reference">25</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Methionine restriction</td>
					<td data-title="Median lifespan increase (treated/control)">111%</td>
					<td data-title="Year Published">2005</td>
					<td data-title="Notes">Methionine restriction increases mouse lifespan, here median lifespan increase in mice that survived at least 1 yr.</td>
					<td data-title="Reference">26</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Rapamycin (3 months)</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Lifespan given from time of treatment which was 23-24 mo, used 24 mo to get percentage so this is an estimate</td>
					<td data-title="Reference">27</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">GHR-BP</td>
					<td data-title="Median lifespan increase (treated/control)">138%</td>
					<td data-title="Year Published">2000</td>
					<td data-title="Notes">Mice deficient in growth hormone receptor / binding protein live longer (female mean, not median, lifespan shown here)</td>
					<td data-title="Reference">28</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">mTOR</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">mTOR depletion extends lifespan</td>
					<td data-title="Reference">29</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">PTEN overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Overexpression of PTEN, a tumor suppressor which counteracts PI3K, extends mouse lifespan</td>
					<td data-title="Reference">30</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Myc (+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">121%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Claim no correlation between weight and lifespan</td>
					<td data-title="Reference">31</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">FGF-21</td>
					<td data-title="Median lifespan increase (treated/control)">139%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Hepatic-specific expression of FGF-21 (which suppresses growth hormone and reduces the production of IGF) increases lifespan, female lifespan shown here</td>
					<td data-title="Reference">32</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">BubR1 overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Kinase which localizes to kinetochore, overexpression increases lifespan</td>
					<td data-title="Reference">33</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">AC5 KO</td>
					<td data-title="Median lifespan increase (treated/control)">132%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">AC5 knockount mice lived longer than control, potentially linked to effects on cAMP production and beta-adrenergic receptor signaling.</td>
					<td data-title="Reference">34</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">17-alpha-estradiol</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">17-alpha-estradiol extended lifespan in males, but not females (as expected)</td>
					<td data-title="Reference">35</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Acarbose</td>
					<td data-title="Median lifespan increase (treated/control)">122%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Acarbose extended male more than female lifespan</td>
					<td data-title="Reference">36</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">TRPV1 -/-</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Resting exchange ratio similar at 16 mo to 3 mo</td>
					<td data-title="Reference">37</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">SRT2104</td>
					<td data-title="Median lifespan increase (treated/control)">106%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Start diet at 28 weeks of age, very small increase if there</td>
					<td data-title="Reference">38</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Hcrt-UCP2</td>
					<td data-title="Median lifespan increase (treated/control)">128%</td>
					<td data-title="Year Published">2006</td>
					<td data-title="Notes">UCP2 under hypocretin promoter lowers core body temp, increases lifespan</td>
					<td data-title="Reference">39</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">G6PD overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Reduces NADP+</td>
					<td data-title="Reference">40</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">IGF-1 Receptor Brain KO (+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">109%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">Brain-specific IGF-1 Receptor +/- mice live longer than WT</td>
					<td data-title="Reference">41</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">SURF-1 KO</td>
					<td data-title="Median lifespan increase (treated/control)">121%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Mutations in SURF1, a cytochrome c oxidase assembly factor, extend lifespan. Mitochondrial.</td>
					<td data-title="Reference">42</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Litter enlargemnet (CR)</td>
					<td data-title="Median lifespan increase (treated/control)">118%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">50% enlargement of litter in first 20 days, to induce caloric restriction</td>
					<td data-title="Reference">43</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">mclk-1 heterozygous</td>
					<td data-title="Median lifespan increase (treated/control)">115%</td>
					<td data-title="Year Published">2005</td>
					<td data-title="Notes">A heterozygous knockout of mclk1 (important in mitochondrial respiration) results in mouse lifespan extension compared to wildtype</td>
					<td data-title="Reference">44</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Nordihydroguairaitic acid</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">NDGA and aspirin extend lifespan by a little bit. Small molecule.</td>
					<td data-title="Reference">45</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Aspirin</td>
					<td data-title="Median lifespan increase (treated/control)">108%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">NDGA and aspirin extend lifespan by a little bit. Small molecule.</td>
					<td data-title="Reference">46</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">SOD mimetic carboxyfullerene</td>
					<td data-title="Median lifespan increase (treated/control)">115%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">Carboxyfullerene, described as an SOD mimetic, increased the lifespan of treated mice compared to wildtype control</td>
					<td data-title="Reference">47</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Removal of visceral fat tissue</td>
					<td data-title="Median lifespan increase (treated/control)">108%</td>
					<td data-title="Year Published">2008</td>
					<td data-title="Notes">Removal of visceral fat tissue increases lifespan over control</td>
					<td data-title="Reference">48</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Low glycotoxin diet</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Low glycotoxin (low levels of AGE&#39;s) shown to extend lifespan</td>
					<td data-title="Reference">49</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Per2 (-/-)</td>
					<td data-title="Median lifespan increase (treated/control)">118%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Lifespan study incomplete</td>
					<td data-title="Reference">50</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Neonatal metformin</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Animals recieved on 3, 5, 7th day after birth - bad for females, good for males.</td>
					<td data-title="Reference">51</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">GHRH KO</td>
					<td data-title="Median lifespan increase (treated/control)">146%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">GHRH (Growth-Hormone Releasing Hormone) disruption extends lifespan, presumably through the insulin/IGF pathway axis</td>
					<td data-title="Reference">52</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Sod-2 overexpresion</td>
					<td data-title="Median lifespan increase (treated/control)">104%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Overexpression of SOD-2 targeted to the mitochondrion increases mouse lifespan relative to wildtype</td>
					<td data-title="Reference">53</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Metallothionein cardiac-specific expression</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2006</td>
					<td data-title="Notes">Cardiac-specific expression of antioxidant metallothionein extended the lifespan of wildtype mice compared to WT FVB control.</td>
					<td data-title="Reference">54</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">IGF1R(+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">121%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Tyrosine kinase receptor activated by IGF1/2</td>
					<td data-title="Reference">55</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Ink4a/Arf/Ink4b</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">Encodes 2 CDKs (p16 and p15), and Arf (upstream of p53)</td>
					<td data-title="Reference">56</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Adult-onset Ghr (-/-)</td>
					<td data-title="Median lifespan increase (treated/control)">100%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Male mice have &gt;2x higher insulin than female mice</td>
					<td data-title="Reference">57</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Ovary Transplantation</td>
					<td data-title="Median lifespan increase (treated/control)">117%</td>
					<td data-title="Year Published">2003</td>
					<td data-title="Notes">Original paper showing that transplantation of young ovaries into old animals could result in lifespan increase</td>
					<td data-title="Reference">58</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">UCP-1 transgenic</td>
					<td data-title="Median lifespan increase (treated/control)">111%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Transgenic mice with skeletal muscle-specific UCP1 had increased longevity. Small increase if there.</td>
					<td data-title="Reference">59</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">PAPP</td>
					<td data-title="Median lifespan increase (treated/control)">131%</td>
					<td data-title="Year Published">2010</td>
					<td data-title="Notes">Knockout of PAPP-A (which enhances IGF-1 activity by degrading the inhibitory IGF-binding protein) increases lifespan over wildtype, female lifespan shown here</td>
					<td data-title="Reference">60</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">CR diet with lard</td>
					<td data-title="Median lifespan increase (treated/control)">132%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">40% decrease starting at 4 months</td>
					<td data-title="Reference">61</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">loss of function of Riib (PKA subunit)</td>
					<td data-title="Median lifespan increase (treated/control)">114%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">Knockout of RIIbeta, a subunit of PKA, increased lifespan in mice compared to wildtype</td>
					<td data-title="Reference">62</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Myostatin (+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">109%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Knockout induces double-muscle mice</td>
					<td data-title="Reference">63</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Akt1 +/-</td>
					<td data-title="Median lifespan increase (treated/control)">113%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Haploinsufficiency of Akt1 increases mouse lifespan relative to wildtype. Insulin/IGF-1 pathway.</td>
					<td data-title="Reference">64</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">miR-17</td>
					<td data-title="Median lifespan increase (treated/control)">117%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Not clear if there is a main function for miR-17</td>
					<td data-title="Reference">65</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">NDGA</td>
					<td data-title="Median lifespan increase (treated/control)">111%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Makes up ~12.5% of the dry weight of leaves</td>
					<td data-title="Reference">66</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">FAT10ko</td>
					<td data-title="Median lifespan increase (treated/control)">119%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Ubiquitin-like protein which can signal for protein to go to proteasome.</td>
					<td data-title="Reference">67</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Intranasal Hsp70</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Seemed to extend lifespan when started at 17 months</td>
					<td data-title="Reference">68</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">RasGRF1(-/-)</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2011</td>
					<td data-title="Notes">Ras-guanine nucleotide exchange factor (Ras-GRF1) -/- mice displayed increased lifespan compared to wildtype.</td>
					<td data-title="Reference">69</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Lmna-Lcs (Lamin C alone)</td>
					<td data-title="Median lifespan increase (treated/control)">113%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Body weight and tumor incidence increase in mice expressing only Lamin-C</td>
					<td data-title="Reference">70</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Cisd2 overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">119%</td>
					<td data-title="Year Published">2011</td>
					<td data-title="Notes">Cisd2 transgenic mice (expressing more of it) lived longer than wildtype. Cisd2 is a transmembrane protein expressed on the mitochondrial outer membrane and associated with a human longevity locus.</td>
					<td data-title="Reference">71</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">metoprolol</td>
					<td data-title="Median lifespan increase (treated/control)">110%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Administration of the beta-adrenerginc receptor blocker metoprolol to mice increased lifespan compared to wildtype</td>
					<td data-title="Reference">72</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">nebivolol</td>
					<td data-title="Median lifespan increase (treated/control)">106%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Administration of the beta-adrenerginc receptor blocker nebivolol to mice increased lifespan compared to wildtype</td>
					<td data-title="Reference">73</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">uPA (in ocular lens/CNS nerve cells)</td>
					<td data-title="Median lifespan increase (treated/control)">118%</td>
					<td data-title="Year Published">1997</td>
					<td data-title="Notes">uPA expression under alpha-crystallin promoter increases lifespan, small/eat less</td>
					<td data-title="Reference">74</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">MIF-1 KO</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2010</td>
					<td data-title="Notes">MIF-1 knockout mutant (T-cell derived cytokine) extends lifespan</td>
					<td data-title="Reference">75</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">mGsta4-null</td>
					<td data-title="Median lifespan increase (treated/control)">113%</td>
					<td data-title="Year Published">2009</td>
					<td data-title="Notes">Enzyme protects against lipid peroxidation, weird that less of its activity might increase lifespan</td>
					<td data-title="Reference">76</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Muscle-specific GHRKO</td>
					<td data-title="Median lifespan increase (treated/control)">109%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Knockout under muscle creatinine kinase promoter</td>
					<td data-title="Reference">77</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">CAM-α(1A)AR mice</td>
					<td data-title="Median lifespan increase (treated/control)">110%</td>
					<td data-title="Year Published">2011</td>
					<td data-title="Notes">Mice with a constitutively active mutant form of the alpha1-adrenergic receptor (CAM-alpha1aAR) lived longer than wildtype control</td>
					<td data-title="Reference">78</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Cardiac-specific catalase overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">113%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Overexpression of catalase specifically in the heart in mice</td>
					<td data-title="Reference">79</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Icariin</td>
					<td data-title="Median lifespan increase (treated/control)">108%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Flavonoid</td>
					<td data-title="Reference">80</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">miR-29 brain-specific KO</td>
					<td data-title="Median lifespan increase (treated/control)">112%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">miR-29 highly expresed in brain during development</td>
					<td data-title="Reference">81</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Bi-maternal mice</td>
					<td data-title="Median lifespan increase (treated/control)">128%</td>
					<td data-title="Year Published">2010</td>
					<td data-title="Notes">Mice prepared to be bi-maternal were found longer-lived than their normal cohort</td>
					<td data-title="Reference">82</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">RNase-L(-/-)</td>
					<td data-title="Median lifespan increase (treated/control)">127%</td>
					<td data-title="Year Published">2007</td>
					<td data-title="Notes">Knockout of RNase-L, which accelerates cell senescence when expressed, increases lifespan in mice compared to wildtype</td>
					<td data-title="Reference">83</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">hMTH1-Tg</td>
					<td data-title="Median lifespan increase (treated/control)">116%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Express high levels of hMTH1 hydrolase, thought to degrade 8-oxodGTP and 8-oxoGTP. Oxidative stress.</td>
					<td data-title="Reference">84</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">DGAT-1 -/-</td>
					<td data-title="Median lifespan increase (treated/control)">126%</td>
					<td data-title="Year Published">2012</td>
					<td data-title="Notes">Knockout of DGAT1, which catalyzes triglyceride synthesis, extends mouse lifespan relative to wildtype</td>
					<td data-title="Reference">85</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">IGFBP-2 overexpression</td>
					<td data-title="Median lifespan increase (treated/control)">105%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Proteins bind IGF1/2, degraded during pregnancy, delay in sexual maturity</td>
					<td data-title="Reference">86</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">PAPP-A on high-fat diet</td>
					<td data-title="Median lifespan increase (treated/control)">105%</td>
					<td data-title="Year Published">2015</td>
					<td data-title="Notes">Males chosen so no adverse developmental effect on fat depots</td>
					<td data-title="Reference">87</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">clk-1(-/-) with clk-1 transgene</td>
					<td data-title="Median lifespan increase (treated/control)">128%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">clk-1 functions in ubiquinone synthesis, but levels weren&#39;t very affected.</td>
					<td data-title="Reference">88</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">AgRP -/-</td>
					<td data-title="Median lifespan increase (treated/control)">110%</td>
					<td data-title="Year Published">2006</td>
					<td data-title="Notes">Neuropeptide that is appetite stimulator, overexpression leads to hyperphagia and obesity.</td>
					<td data-title="Reference">89</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Bone marrow transplantation</td>
					<td data-title="Median lifespan increase (treated/control)">106%</td>
					<td data-title="Year Published">2013</td>
					<td data-title="Notes">Bone marrow transplantation from young to old mice was claimed to extend lifespan</td>
					<td data-title="Reference">90</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Young blood injections</td>
					<td data-title="Median lifespan increase (treated/control)">94%</td>
					<td data-title="Year Published">2014</td>
					<td data-title="Notes">Resulted in decreased lifespan</td>
					<td data-title="Reference">91</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Nas(-/-) mice</td>
					<td data-title="Median lifespan increase (treated/control)">125%</td>
					<td data-title="Year Published">2011</td>
					<td data-title="Notes">Hyposulfatemic NaS1 null mice (Nas1 -/-) had an increased lifespan compared to wildtype control.</td>
					<td data-title="Reference">92</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Cyclophilin D (+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">119%</td>
					<td data-title="Year Published">2017</td>
					<td data-title="Notes">Decrease in maximum lifespan</td>
					<td data-title="Reference">93</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">PAPP-A in adults</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2017</td>
					<td data-title="Notes">Tamoxifen-induced knockdown</td>
					<td data-title="Reference">94</td>
				</tr>
			

				<tr>
					<td data-title="Intervention">Mtbp (+/-)</td>
					<td data-title="Median lifespan increase (treated/control)">120%</td>
					<td data-title="Year Published">2016</td>
					<td data-title="Notes">Rotarod, open field, blood glucose, insulin, IGF-1 were the same.</td>
					<td data-title="Reference">95</td>
				</tr>
			
			</div></div>
  </body>
</html>
